Hepatitis B and D virus entry

Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, wh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature reviews. Microbiology Jg. 23; H. 5; S. 318
Hauptverfasser: Watashi, Koichi, Shionoya, Kaho, Kobayashi, Chisa, Morita, Takeshi
Format: Journal Article
Sprache:Englisch
Veröffentlicht: England 01.05.2025
Schlagworte:
ISSN:1740-1534, 1740-1534
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.
AbstractList Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.
Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular reservoir of viral persistence and a key obstacle for HBV cure. The restricted entry of HBV into specific cell types determines the nature of HBV, which has a narrow host range in tissues and species. Hepatitis D virus (HDV) shares viral surface antigens with HBV and thus follows a similar entry mechanism at its early stages. In late 2012, sodium taurocholate cotransporting polypeptide was discovered as an HBV and HDV entry receptor. Since then, the mechanisms of HBV and HDV entry have been extensively analysed. These analyses have expanded our understanding of HBV and HDV host tropism and have provided new strategies for the development of antiviral agents. Notably, the structures of sodium taurocholate cotransporting polypeptide and its interaction with the 2-48 amino acid region of viral preS1 have been recently solved. These findings will stimulate further entry studies. In this Review, we summarize current understanding of HBV and HDV entry and future perspectives.
Author Watashi, Koichi
Morita, Takeshi
Kobayashi, Chisa
Shionoya, Kaho
Author_xml – sequence: 1
  givenname: Koichi
  orcidid: 0000-0002-4536-9966
  surname: Watashi
  fullname: Watashi, Koichi
  email: kwatashi@niid.go.jp, kwatashi@niid.go.jp
  organization: Department of Applied Biological Science, Tokyo University of Science, Noda, Japan. kwatashi@niid.go.jp
– sequence: 2
  givenname: Kaho
  surname: Shionoya
  fullname: Shionoya, Kaho
  organization: Department of Applied Biological Science, Tokyo University of Science, Noda, Japan
– sequence: 3
  givenname: Chisa
  surname: Kobayashi
  fullname: Kobayashi, Chisa
  organization: Department of Applied Biological Science, Tokyo University of Science, Noda, Japan
– sequence: 4
  givenname: Takeshi
  surname: Morita
  fullname: Morita, Takeshi
  organization: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39572840$$D View this record in MEDLINE/PubMed
BookMark eNpNj0tLxDAUhYOMOA_9A4LSpZtobnLTJEsdHyMMuNF1uU1TqPRl0wrz7y04gptzzuLjcM6aLdquDYxdgrgFoexdRNDGcSGRCwAJXJ6wFRgUHLTCxb-8ZOsYP4WQWht5xpbKzW5RrNjVLvQ0VmMVk4eE2iJ5TL6rYYpJaMfhcM5OS6pjuDj6hn08P71vd3z_9vK6vd9zr4weeeEd5eBdWmAB2lOJpUwtIQV03pWkUmnJBw3BGWsDgUYgnDcYW-apJLlhN7-9_dB9TSGOWVNFH-qa2tBNMVOgwOpZcEavj-iUN6HI-qFqaDhkf5fkDwkxTbU
CitedBy_id crossref_primary_10_1016_j_antiviral_2025_106213
crossref_primary_10_3390_v17081100
ContentType Journal Article
Copyright 2024. Springer Nature Limited.
Copyright_xml – notice: 2024. Springer Nature Limited.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1038/s41579-024-01121-2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Biology
EISSN 1740-1534
ExternalDocumentID 39572840
Genre Journal Article
Review
GroupedDBID ---
.55
0R~
123
29M
36B
39C
4.4
53G
70F
7RV
7X7
88E
88I
8AO
8C1
8CJ
8FE
8FH
8FI
8FJ
8R4
8R5
AARCD
AAWYQ
AAYZH
ABAWZ
ABDBF
ABJNI
ABLJU
ABUWG
ACGFO
ACGFS
ACMJI
ACPRK
ACUHS
ADBBV
ADFRT
AENEX
AEUYN
AFANA
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALPWD
AMTXH
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BKSAR
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
D1J
DB5
DU5
DWQXO
EAD
EAP
EAS
EBS
ECM
EE.
EIF
EJD
EMB
EMK
EMOBN
ESX
EX3
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IH2
IHR
INH
INR
ITC
LGEZI
LK8
LOTEE
M1P
M2P
M7P
MM.
N9A
NADUK
NAPCQ
NFIDA
NNMJJ
NPM
NXXTH
O9-
ODYON
P2P
PCBAR
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
QF4
QM4
QN7
QO4
RNR
RNT
RNTTT
SHXYY
SIXXV
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TSG
TUS
UKHRP
WOW
X7M
7X8
ABFSG
ACSTC
AEZWR
AFHIU
AHWEU
AIXLP
ATHPR
ID FETCH-LOGICAL-c375t-dc9ab1c96d4d15caf4f268a4ae49c9fa3628ace51e9788ea1541a495778fb62a2
IEDL.DBID 7X8
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001360311600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1740-1534
IngestDate Thu Sep 04 16:27:31 EDT 2025
Thu Apr 17 08:38:01 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License 2024. Springer Nature Limited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-dc9ab1c96d4d15caf4f268a4ae49c9fa3628ace51e9788ea1541a495778fb62a2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-4536-9966
PMID 39572840
PQID 3131851314
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3131851314
pubmed_primary_39572840
PublicationCentury 2000
PublicationDate 2025-05-01
PublicationDateYYYYMMDD 2025-05-01
PublicationDate_xml – month: 05
  year: 2025
  text: 2025-05-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Nature reviews. Microbiology
PublicationTitleAlternate Nat Rev Microbiol
PublicationYear 2025
SSID ssj0025572
Score 2.487868
SecondaryResourceType review_article
Snippet Hepatitis B virus (HBV) entry is the initial step of viral infection, leading to the formation of covalently closed circular DNA, which is a molecular...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 318
SubjectTerms Animals
Hepatitis B - virology
Hepatitis B Surface Antigens - metabolism
Hepatitis B virus - physiology
Hepatitis D - virology
Hepatitis Delta Virus - physiology
Humans
Organic Anion Transporters, Sodium-Dependent - metabolism
Receptors, Virus - metabolism
Symporters - metabolism
Virus Internalization
Title Hepatitis B and D virus entry
URI https://www.ncbi.nlm.nih.gov/pubmed/39572840
https://www.proquest.com/docview/3131851314
Volume 23
WOSCitedRecordID wos001360311600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFH-oU_Di98fUSQWvYU2bpslJ_Bq7OHZQ2K28pgl46ea6DfzvfWk7PQmCl0BpC036Xn6_l_eSH8Ct1CopjCX_TmJHAYqOmXJSstTxmK4kOhfWYhPpaKQmEz1uF9yqtqxyPSfWE3UxNX6NvB9zv8-XGnE3-2BeNcpnV1sJjU3o0H3trTqdfGcRiC3X4k1EukNGni3aTTNhrPoVAVeqGSEUBdM84iz6nWLWUDPY_-9HHsBeSzKD-8YqDmHDlkew08hOfh5Db2h9HfXivQoeAiyL4ClYvc-XVVCrjJzA2-D59XHIWpkEZuI0WbDCaMy50bIQBU8MOuEiqVCgFdpohwRRCo1NuKWIUVkk0sSR4qI0VS6XEUansFVOS3sOgYlzro30Z5KFIs-NckZibhBRFPR41IWbdb8zMkOfW8DSTpdV9tPzLpw1g5fNmvMyMp8KJBQML_7w9iXsRl5hty4pvIKOIye0Pdg2KxqU-XX9f6kdjV--AClPrG0
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatitis+B+and+D+virus+entry&rft.jtitle=Nature+reviews.+Microbiology&rft.au=Watashi%2C+Koichi&rft.au=Shionoya%2C+Kaho&rft.au=Kobayashi%2C+Chisa&rft.au=Morita%2C+Takeshi&rft.date=2025-05-01&rft.eissn=1740-1534&rft.volume=23&rft.issue=5&rft.spage=318&rft_id=info:doi/10.1038%2Fs41579-024-01121-2&rft_id=info%3Apmid%2F39572840&rft_id=info%3Apmid%2F39572840&rft.externalDocID=39572840
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1740-1534&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1740-1534&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1740-1534&client=summon